About

David Klimstra, M.D. is Founder and Chief Medical Officer at Paige, the first company to receive FDA approval for an AI product in digital pathology, Paige Prostate. He also serves as Medical Consultant at Memorial Sloan Kettering Cancer Center and Professor of Pathology and Laboratory Medicine at Weill Medical College of Cornell University. An internationally recognized expert on the pathology of tumors of the digestive system, pancreas, liver, and neuroendocrine system, he has published over 425 primary articles and his research focuses on the correlation of morphological and immunohistochemical features of tumors of the gastrointestinal tract, liver, biliary tree, and (most notably) pancreas with their clinical and molecular characteristics. Dr. Klimstra received his M.D. and completed a residency in anatomic pathology at Yale University, and he completed fellowship training in oncologic surgical pathology at Memorial Sloan Kettering Cancer Center.

Subscribe For The Latest Impact Updates

Subscribe to get the latest Impact episodes delivered right to your inbox each week!
Invalid email address
We promise not to spam you or share your information. You can unsubscribe at any time.

Episodes